Effects of Tesamorelin on non-alcoholic fatty liver disease in HIV: a randomized, double-blind, multicentre trial
Medication selection depends on medical history, safety factors, diagnosis, availability, insurance rules, and provider judgment
Longer term For longer protocols, review IGF-1 and metabolic trends periodically with a clinician
Understand policies before purchasing
Growth Hormone Secretagogues This group brings together CJC-1295, Ipamorelin, and Sermorelin
By targeting both GLP-1 and the Glucose-dependent insulinotropic polypeptide (GIP) receptor, it demonstrated a synergistic effect that surpassed GLP-1 mono-agonists